Plus Therapeutics (PSTV.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec21

Plus Therapeutics Receives Average Analyst 'Moderate Buy' Rating

10:38

Oct31

Plus Therapeutics released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 3.846 M and EPS of USD -29.5631

03:00

Plus Therapeutics released FY2025 Q3 earnings on October 30 (EST), actual revenue USD 1.397 M (forecast USD 1.5 M), actual EPS USD -0.0411 (forecast USD -0.0275)

03:00

Sep25

UnitedHealth Insurance Reaches National Coverage Agreement with Plus Therapeutics for CNSide CSF Test

12:22

Aug15

Plus Therapeutics Meets NASDAQ Listing Rules and Receives Compliance Extension

13:49

Plus Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.39 M (forecast USD 1.486 M), actual EPS USD -0.01 (forecast USD -0.09)

03:00